OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors
Mihaela Aldea, Marco Tagliamento, Arnaud Bayle, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 17
Mihaela Aldea, Marco Tagliamento, Arnaud Bayle, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 17
Showing 17 citing articles:
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M.F. Mosele, C. Benedikt Westphalen, A Stenzinger, et al.
Annals of Oncology (2024) Vol. 35, Iss. 7, pp. 588-606
Open Access | Times Cited: 89
M.F. Mosele, C. Benedikt Westphalen, A Stenzinger, et al.
Annals of Oncology (2024) Vol. 35, Iss. 7, pp. 588-606
Open Access | Times Cited: 89
Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer
Arianna Marinello, Marco Tagliamento, Arianna Pagliaro, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102791-102791
Open Access | Times Cited: 9
Arianna Marinello, Marco Tagliamento, Arianna Pagliaro, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102791-102791
Open Access | Times Cited: 9
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
Marco Sposito, Lorenzo Belluomini, Riccardo Nocini, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Marco Sposito, Lorenzo Belluomini, Riccardo Nocini, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Apport de la génomique dans la prise en charge des cancers
Étienne Rouleau, Lucie Karayan‐Tapon, Marie‐Dominique Galibert, et al.
Revue Francophone des Laboratoires (2025) Vol. 2025, Iss. 568, pp. 67-74
Closed Access
Étienne Rouleau, Lucie Karayan‐Tapon, Marie‐Dominique Galibert, et al.
Revue Francophone des Laboratoires (2025) Vol. 2025, Iss. 568, pp. 67-74
Closed Access
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
Sophie M. Ernst, Mihaela Aldea, Jan H. von der Thüsen, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Sophie M. Ernst, Mihaela Aldea, Jan H. von der Thüsen, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Clonal Hematopoiesis: Updates and Implications at the Solid Tumor-Immune Interface
Marco M. Buttigieg, Michael J. Rauh
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 10
Marco M. Buttigieg, Michael J. Rauh
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 10
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications
Claudia Parisi, Marco Tagliamento, Laïla Belcaid, et al.
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100007-100007
Open Access | Times Cited: 9
Claudia Parisi, Marco Tagliamento, Laïla Belcaid, et al.
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100007-100007
Open Access | Times Cited: 9
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma
Julien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 9
Julien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 9
Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases
Aakash Desai, Lincoln W. Pasquina, Candice Nulsen, et al.
The Journal of Liquid Biopsy (2024) Vol. 4, pp. 100140-100140
Open Access | Times Cited: 3
Aakash Desai, Lincoln W. Pasquina, Candice Nulsen, et al.
The Journal of Liquid Biopsy (2024) Vol. 4, pp. 100140-100140
Open Access | Times Cited: 3
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients
Damien Vasseur, Ahmadreza Arbab, Fabiola Giudici, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Damien Vasseur, Ahmadreza Arbab, Fabiola Giudici, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications
Juan Carlos Laguna, B. Pastor, I. Nalda, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 9, pp. 1420-1431
Closed Access | Times Cited: 3
Juan Carlos Laguna, B. Pastor, I. Nalda, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 9, pp. 1420-1431
Closed Access | Times Cited: 3
Implementing evidence‐based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024
Alan H. Bryce, Neeraj Agarwal, Himisha Beltran, et al.
Cancer (2024) Vol. 131, Iss. 1
Closed Access | Times Cited: 3
Alan H. Bryce, Neeraj Agarwal, Himisha Beltran, et al.
Cancer (2024) Vol. 131, Iss. 1
Closed Access | Times Cited: 3
Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer
Félix Blanc‐Durand, Géraldine M. Camilleri, Arnaud Bayle, et al.
Cancer (2024) Vol. 130, Iss. 19, pp. 3311-3320
Open Access | Times Cited: 2
Félix Blanc‐Durand, Géraldine M. Camilleri, Arnaud Bayle, et al.
Cancer (2024) Vol. 130, Iss. 19, pp. 3311-3320
Open Access | Times Cited: 2
Cell-Free DNA in Hematologic Malignancies
Joseph G. Schroers‐Martin, Ash A. Alizadeh
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1491-1499
Closed Access | Times Cited: 1
Joseph G. Schroers‐Martin, Ash A. Alizadeh
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1491-1499
Closed Access | Times Cited: 1
Exploring clonal hematopoiesis and its impact on aging, cancer, and patient care
Julieta Elena Rodriguez, Jean Baptiste Micol, Capucine Baldini
Aging (2023)
Open Access | Times Cited: 2
Julieta Elena Rodriguez, Jean Baptiste Micol, Capucine Baldini
Aging (2023)
Open Access | Times Cited: 2
Clinical and molecular features of early onset pancreatic adenocarcinoma
Maxime Rémond, Cristina Smolenschi, Anthony Tarabay, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 11, pp. 1969-1981
Open Access
Maxime Rémond, Cristina Smolenschi, Anthony Tarabay, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 11, pp. 1969-1981
Open Access
